1. Core Values: Restructuring Industrialization Logic of Biomanufacturing
Eliminate scale-up effects: Multi-scale simulation and digital twin technology accurately predict discrepancies in hydrodynamics, heat and mass transfer, as well as cellular metabolic behaviors across bench, pilot and commercial production scales. Yield loss caused by scale-up effects is curbed within 5%, compared with traditional 10%-30% decline in microbial fermentation scale-up.
Cut industrial risks and costs: Reduce iterative process tests in pilot and mass production stages, shortening industrialization cycle from 1-2 years to 3-6 months. Intelligent feeding strategies slash carbon source consumption waste by over 20%.
Enhance process stability and controllability: Real-time monitoring and intelligent regulation enable precise intervention during fermentation. The coefficient of variation of critical quality attributes in antibody fermentation drops from 15% to below 5%, complying with stringent quality control standards in biopharmaceuticals.
Enable flexible and intelligent manufacturing: Digital twin-based bioreactors support rapid switching of production strains and target products to meet customized manufacturing demands. The industry evolves from single-product mass production to multi-product flexible production.
2. Key Scientific and Technical Bottlenecks
2.1 Core Scientific Problems
Fermentation involves interactions at cellular, reactor and procedural scales. Shear force inside reactors alters cell morphology and redistributes metabolic flux. The primary challenge lies in revealing cross-scale coupling rules and establishing models balancing accuracy and computational efficiency.
Living cells adjust metabolic activities dynamically responding to variations in pH, dissolved oxygen and substrate concentration, accompanied by individual and population heterogeneity. It is essential to quantify biological uncertainties and build robust adaptive models for accurate process prediction and regulation.
2.2 Core Technical Bottlenecks
Virtual models fail real-time synchronous updating due to high computational complexity. Mismatched sensor data and model parameters degrade simulation precision. Besides, models show poor adaptability to unexpected disturbances such as strain mutation and raw material impurities.
Off-line detection cannot feed back metabolic parameters instantly, while online sensors suffer unsatisfactory detection limit and anti-interference capacity. Intracellular indicators including metabolites and enzyme activity lack effective real-time testing approaches, resulting in low prediction accuracy via indirect deduction.
Conventional PID control fails to cope with nonlinear and dynamic biological characteristics. AI algorithms face insufficient qualified batch data, weak generalization performance from bench scale to commercial scale, and low interpretability that cannot satisfy FDA Process Analytical Technology regulatory requirements.
3. Systematic Development Route: From Multi-scale Modeling to Closed-loop Intelligent Control
Step 1: Construct multi-scale coupled fermentation models
Cellular-scale model: Adopt genome-scale metabolic models, dynamic flux balance analysis and machine learning to characterize cell growth, metabolism and product synthesis under varying environments.
Reactor-scale model: Employ computational fluid dynamics to simulate flow velocity, pressure, temperature and dissolved oxygen distribution, analyzing hydrodynamic differences among reactors of different volumes.
Process-scale model: Utilize statistical learning and system dynamics to assess batch variation and process stability.
Coupling strategy: Adopt top-down and bottom-up methods to realize interactive data transmission and collaborative optimization among scales.
Step 2: Integrate high-sensitivity online sensors and data acquisition system
Step 3: Process parameter prediction and optimization based on AI algorithms
Parameter prediction: LSTM and GRU deep learning models forecast yield and cell vitality. Transfer and semi-supervised learning address small-data limitations and enhance model generalization.
Process optimization: Reinforcement learning and NSGA-Ⅲ multi-objective algorithms optimize feeding rate, temperature and aeration to balance yield, stability and cost.
Interpretability improvement: SHAP and LIME explainable AI visualize decision logic. Hybrid mechanism-data models elevate model robustness and compliance.
Step 4: Establish intelligent feedback control and automatic platform
4. Typical Application Cases
Case 1: Digital twin scale-up of CHO cell culture (Biopharmaceutical Industry)
Case 2: Intelligent regulation of enzyme synthesis by Escherichia coli (Enzyme Engineering)
5. Core Challenges and Future Trends
5.1 Current Major Challenges
5.2 Future Development Trends
Deep integration of digital twin and Design-Build-Test-Learn cycle accelerates iterative upgrading of strain design, process optimization and scale-up production.
Collaborative edge-cloud computing realizes local real-time regulation and centralized global model iteration.
Genetically encoded biosensors achieve specific intracellular parameter monitoring, cooperating with AI to boost model performance.
Self-autonomous bioreactors with self-perception, prediction, regulation and learning capabilities will achieve commercial popularization, driving comprehensive intelligent transformation of biomanufacturing.
6. Conclusion
